NEW Research Opportunity: You may be eligible to participate in a new depression study. Find Out More
.jpg)
Mood Disorders, ADHD and Obesity: Converging Neuroscience, Clinical Overlap and Novel Treatments
Date: February 9, 2019
Location: Mississauga, Ontario, Canada
This archived, self-directed learning activity is available for personal viewing and is based on the live event held in online on February 9th 2019. The program involved a multidisciplinary faculty of clinician researchers from SUNY Upstate Medical University, Mount Sinai Hospital, and the University of Toronto.
This program is intended for family physicians, psychiatrists, endocrinologists, and allied health professionals, who provide care for people with mood disorders, ADHD and/or diabetes.
Learning Objectives
1. Become familiar with the latest scientific evidence linking obesity and diabetes to CNS disease
2. Understand how depression and ADHD can contribute to obesity and diabetes
3. Learn about state-of-the-art treatments for ADHD, depression, obesity and diabetes
The Panel
Dr. Roger McIntyre
MD, FRCPC
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Talk 1: Major Depressive Disorder and Bipolar Disorder
Talk 2: Obesity Inflammation and the Brain: Implications for Bidirectional Metastasis and Metaboptosis
Dr. Harpreet Bajaj
MD, MPH, ECNU, FACE
Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON
Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto
Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section
Columnist and blogger, www.medscape.com
Founder, “STOP Diabetes” Foundation Inc.
Talk: The Impact of Diabetes Management on Mood Disorders & ADHD
Dr. Thomas Schwarts
MD
Professor of Psychiatry & Behavioral Sciences
SUNY Upstate Medical University, Syracuse, NY